Back to Search Start Over

Programmed cell death‐1 3′‐untranslated region polymorphism is associated with spontaneous clearance of hepatitis B virus infection

Authors :
Hajar Chihab
Fatima‐Zahra Jadid
Pelagia Foka
Imane Zaidane
Raouia El Fihry
Urania Georgopoulou
Agnes Marchio
Abdellah Elhabazi
Mohammed Chair
Pascal Pineau
Sayeh Ezzikouri
Soumaya Benjelloun
Laboratoire des Hépatites Virales [Casablanca, Maroc] (LHV)
Institut Pasteur du Maroc
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
Université Chouaib Doukkali (UCD)
Molecular Virology Laboratory = Laboratoire de Virologie moléculaire [Athènes]
Institut Pasteur Hellénique
Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut Pasteur du Maroc (Morocco)
Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Journal of Medical Virology, Journal of Medical Virology, 2018, 90 (11), pp.1730-1738. ⟨10.1002/jmv.25265⟩, Journal of Medical Virology, Wiley-Blackwell, 2018, 90 (11), pp.1730-1738. ⟨10.1002/jmv.25265⟩
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

International audience; Hepatitis B virus (HBV)-specific CD8+ T cells play an important role in the clearance of HBV infection. Programmed cell death-1 (PD-1), an immunosuppressive molecule that regulates T-cell activation and peripheral immune tolerance, is increasingly shown to influence the outcome of HBV infection. rs10204525, a single-nucleotide polymorphism in the 3'-untranslated region (3'-UTR) of PD-1, has been associated with susceptibility and disease progression of chronic HBV infection in far-eastern patients. The aim of our study was to assess the impact of rs10204525 variation on HBV infection in Moroccan patients. A total of 236 patients with chronic HBV infection and 134 individuals with spontaneous HBV resolution were genotyped using a Taqman assay. In addition, PD-1 mRNA expression in peripheral blood nuclear cells was determined by quantitative reverse-transcription polymerase chain reaction. We found that the AA genotype is protective (odds ratio, 0.43; 95% confidence interval, 0.19 to 0.97; P = 0.038) against HBV infection. Interestingly, PD-1 messenger RNA (mRNA) expression analysis has revealed that chronic HBV carriers with GG and GA displayed higher levels of PD-1 mRNA compared with corresponding genotypes in resolved subjects (P = 0.031 and 0.014, respectively). Our data suggest that Mediterranean HBV-infected patients carrying PD-1 GG and GA genotypes at rs10204525 have high PD-1 mRNA expression and may be more prone to installation of chronicity.

Details

Language :
English
ISSN :
01466615 and 10969071
Database :
OpenAIRE
Journal :
Journal of Medical Virology, Journal of Medical Virology, 2018, 90 (11), pp.1730-1738. ⟨10.1002/jmv.25265⟩, Journal of Medical Virology, Wiley-Blackwell, 2018, 90 (11), pp.1730-1738. ⟨10.1002/jmv.25265⟩
Accession number :
edsair.doi.dedup.....b5ffbb759d29535641f6d969e0694d29
Full Text :
https://doi.org/10.1002/jmv.25265⟩